Eli Lilly celebrates 150 years of innovation and looks to the future of research
The pharmaceutical company Eli Lilly has officially celebrated its 150th anniversary. Founded in 1876 by Eli Lilly, a chemist and veteran of the American Civil War, the company has over time become one of the global pillars in the healthcare sector, with a significant presence in Italy as well.
Over the course of a century and a half, the company has helped transform modern medicine. Among the most important achievements reached is the mass production of insulin in the 1920s, which radically changed the lives of people affected by diabetes. Today, research is focused on new frontiers, such as neurodegenerative diseases, oncology, and immunology.
In Italy, too, Eli Lilly plays a fundamental role. The production center in Sesto Fiorentino, in the province of Florence, represents one of the most advanced hubs globally for the production of biotechnological drugs. This facility not only guarantees the supply of essential medicines for the Italian market but also exports innovation to over 60 countries around the world.
Looking to the future, the company has announced significant new investments in research and development. The main objective is to accelerate the discovery of personalized therapies, using new digital technologies and artificial intelligence to make treatments more effective and accessible for patients.
In conclusion, the 150-year milestone represents not just a celebration of the past, but a starting point for the medical challenges of the coming decades. With a strong commitment to sustainability and scientific innovation, Eli Lilly continues to invest in Italian talent and infrastructure to improve global public health.